Polly Klane Appointed as General Counsel at Corebridge Financial
January 7, 2025 - 23:04
HOUSTON, January 07, 2025—Corebridge Financial, Inc. has announced the appointment of Polly Klane as the new General Counsel, effective February. In her role, Klane will report directly to Chief Executive Officer Kevin Hogan and will be responsible for overseeing the company’s legal, compliance, regulatory, corporate secretary, and government affairs functions.
Klane's extensive experience in the legal sector positions her well to contribute to Corebridge's strategic objectives. She will also join the Executive Leadership Team, where her insights will help shape the company's direction and governance. This transition follows the retirement of Christine Nixon, who held the General Counsel position and announced her departure last year after a distinguished career with the company.
Klane’s appointment signals Corebridge's commitment to strengthening its legal framework and enhancing its compliance measures as it navigates the complexities of the financial landscape. The company looks forward to her leadership and expertise in fostering a robust legal environment.
MORE NEWS
June 23, 2026 - 20:50
Bitcoin 'vulnerable to further weakness' as token tumbles amid tech routBitcoin took a sharp hit on Tuesday, falling in tandem with a broad sell-off in technology stocks that rattled global markets. The leading cryptocurrency dropped more than 5% in a single session,...
June 23, 2026 - 18:40
SpaceX stock dips below $150 debut before reboundingSpaceX`s stock took another hit on Tuesday, sliding below its initial public offering price of $150 before recovering later in the session. The sell-off extended a rough stretch for the company`s...
June 22, 2026 - 17:54
SpaceX stock tumbles 16.4%, shaving off most IPO gains since debutSpaceX shares took another sharp hit on Monday, putting the company on track for three consecutive days of losses. The steep decline has wiped out the majority of the gains the stock had racked up...
June 22, 2026 - 04:41
West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth NarrativeWest Pharmaceutical Services (WST) stock has drawn attention after recent share price moves, with investors weighing its role in drug containment and delivery in relation to current valuation...